XSES
BTOU
Market cap60mUSD
Oct 09, Last price
0.03USD
1D
-2.94%
1Q
-36.54%
Jan 2017
-95.62%
IPO
-95.42%
Name
Manulife US Real Estate Investment Trust
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Manulife US Real Estate Investment Trust (Manulife US REIT) holds the distinction of being the first dedicated US office real estate investment trust to be listed on an Asian exchange. As a REIT traded in Singapore, its core investment mandate involves acquiring and managing, either directly or indirectly, a collection of income-generating office properties and associated real estate assets in prominent U.S. markets. The trust's current portfolio encompasses nine prime, freehold office buildings, all classified as either 'Trophy' or 'Class A' quality, strategically positioned across California, Atlanta, New Jersey, and the Washington D.C. Metropolitan Area. Appraised at US$2.1 billion as of December 31, 2019, this entire collection of assets boasts a total Net Lettable Area of 4.7 million square feet and an impressive occupancy rate of 95.8%.
Key people
Marc Feliciano
Non-Executive Chairman of the Board of the Manager · since 2023
John Casasante
Chief Executive Officer, Chief Investment Officer of the Manager · since 2024
Mushtaque Muhammad Ali
Chief Financial Officer of the Manager · since 2024
Chia Yee Choong
Head of Finance of the Manager · since 2021
Liu Wylyn
Head of Investor Relations · since 2025
Chiu Suan Chua
Company Secretary, Chief Corporate Officer of the Manager · since 2024
Veronica McCann
Non-Independent Non-Executive Director · since 2024
Kian Koon Choo
Non-Executive Independent Director of the Manager · since 2017
Chiew Koh Cher
Non-Executive Lead Independent Director of the Manager · since 2020
Koh Tay
Non-Executive Independent Director of the Manager · since 2020
Headquarters & legal address
12, Marina Boulevard
Marina Bay Financial Centre
Level 44
Tower 3
Singapore 018982
SG
Marina Bay Financial Centre
Level 44
Tower 3
Singapore 018982
SG
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||